The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pancreatic Beta-Cell Protection Market Research Report 2025

Global Pancreatic Beta-Cell Protection Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1799420

No of Pages : 97

Ask Your Query

Synopsis

Beta Cells. Beta cells are unique cells in the pancreas that produce, store and release the hormone insulin.

The global Pancreatic Beta-Cell Protection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Pancreatic Beta-Cell Protection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Pancreatic Beta-Cell Protection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Pancreatic Beta-Cell Protection in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Pancreatic Beta-Cell Protection include ViaCyte, PharmaCyte Biotech, Boehringer Ingelheim, GalaxoSmithKline, Beta-Cell NV, Novartis, Janssen Research & Development, Pfizer Inc and BioLineRx, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pancreatic Beta-Cell Protection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pancreatic Beta-Cell Protection.

Report Scope

The Pancreatic Beta-Cell Protection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pancreatic Beta-Cell Protection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pancreatic Beta-Cell Protection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • ViaCyte
  • PharmaCyte Biotech
  • Boehringer Ingelheim
  • GalaxoSmithKline
  • Beta-Cell NV
  • Novartis
  • Janssen Research & Development
  • Pfizer Inc
  • BioLineRx
  • Genentech
  • Novo Nordisk
  • Sanofi
  • Osiris Therapeutics
  • Beta-O2 Technologies Ltd
  • Transition Therapeutics

Segment by Type

  • Stem Cell Based
  • Gene Therapies
  • RNA Based Therapies
  • Monoclonal Antibodies (MAbs)
  • Phytotherapy

Segment by Application

  • Hospital
  • Medical Research Laboratory
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pancreatic Beta-Cell Protection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stem Cell Based
1.2.3 Gene Therapies
1.2.4 RNA Based Therapies
1.2.5 Monoclonal Antibodies (MAbs)
1.2.6 Phytotherapy
1.3 Market by Application
1.3.1 Global Pancreatic Beta-Cell Protection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pancreatic Beta-Cell Protection Market Perspective (2019-2030)
2.2 Pancreatic Beta-Cell Protection Growth Trends by Region
2.2.1 Global Pancreatic Beta-Cell Protection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pancreatic Beta-Cell Protection Historic Market Size by Region (2019-2024)
2.2.3 Pancreatic Beta-Cell Protection Forecasted Market Size by Region (2025-2030)
2.3 Pancreatic Beta-Cell Protection Market Dynamics
2.3.1 Pancreatic Beta-Cell Protection Industry Trends
2.3.2 Pancreatic Beta-Cell Protection Market Drivers
2.3.3 Pancreatic Beta-Cell Protection Market Challenges
2.3.4 Pancreatic Beta-Cell Protection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue
3.1.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue (2019-2024)
3.1.2 Global Pancreatic Beta-Cell Protection Revenue Market Share by Players (2019-2024)
3.2 Global Pancreatic Beta-Cell Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pancreatic Beta-Cell Protection Revenue
3.4 Global Pancreatic Beta-Cell Protection Market Concentration Ratio
3.4.1 Global Pancreatic Beta-Cell Protection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Beta-Cell Protection Revenue in 2023
3.5 Pancreatic Beta-Cell Protection Key Players Head office and Area Served
3.6 Key Players Pancreatic Beta-Cell Protection Product Solution and Service
3.7 Date of Enter into Pancreatic Beta-Cell Protection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pancreatic Beta-Cell Protection Breakdown Data by Type
4.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Type (2019-2024)
4.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2025-2030)
5 Pancreatic Beta-Cell Protection Breakdown Data by Application
5.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Application (2019-2024)
5.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pancreatic Beta-Cell Protection Market Size (2019-2030)
6.2 North America Pancreatic Beta-Cell Protection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pancreatic Beta-Cell Protection Market Size by Country (2019-2024)
6.4 North America Pancreatic Beta-Cell Protection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pancreatic Beta-Cell Protection Market Size (2019-2030)
7.2 Europe Pancreatic Beta-Cell Protection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pancreatic Beta-Cell Protection Market Size by Country (2019-2024)
7.4 Europe Pancreatic Beta-Cell Protection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size (2019-2030)
8.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2019-2024)
8.4 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pancreatic Beta-Cell Protection Market Size (2019-2030)
9.2 Latin America Pancreatic Beta-Cell Protection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2019-2024)
9.4 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size (2019-2030)
10.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2019-2024)
10.4 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ViaCyte
11.1.1 ViaCyte Company Detail
11.1.2 ViaCyte Business Overview
11.1.3 ViaCyte Pancreatic Beta-Cell Protection Introduction
11.1.4 ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.1.5 ViaCyte Recent Development
11.2 PharmaCyte Biotech
11.2.1 PharmaCyte Biotech Company Detail
11.2.2 PharmaCyte Biotech Business Overview
11.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Introduction
11.2.4 PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.2.5 PharmaCyte Biotech Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Introduction
11.3.4 Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 GalaxoSmithKline
11.4.1 GalaxoSmithKline Company Detail
11.4.2 GalaxoSmithKline Business Overview
11.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Introduction
11.4.4 GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.4.5 GalaxoSmithKline Recent Development
11.5 Beta-Cell NV
11.5.1 Beta-Cell NV Company Detail
11.5.2 Beta-Cell NV Business Overview
11.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Introduction
11.5.4 Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.5.5 Beta-Cell NV Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Pancreatic Beta-Cell Protection Introduction
11.6.4 Novartis Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 Janssen Research & Development
11.7.1 Janssen Research & Development Company Detail
11.7.2 Janssen Research & Development Business Overview
11.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Introduction
11.7.4 Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.7.5 Janssen Research & Development Recent Development
11.8 Pfizer Inc
11.8.1 Pfizer Inc Company Detail
11.8.2 Pfizer Inc Business Overview
11.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Introduction
11.8.4 Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.8.5 Pfizer Inc Recent Development
11.9 BioLineRx
11.9.1 BioLineRx Company Detail
11.9.2 BioLineRx Business Overview
11.9.3 BioLineRx Pancreatic Beta-Cell Protection Introduction
11.9.4 BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.9.5 BioLineRx Recent Development
11.10 Genentech
11.10.1 Genentech Company Detail
11.10.2 Genentech Business Overview
11.10.3 Genentech Pancreatic Beta-Cell Protection Introduction
11.10.4 Genentech Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.10.5 Genentech Recent Development
11.11 Novo Nordisk
11.11.1 Novo Nordisk Company Detail
11.11.2 Novo Nordisk Business Overview
11.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Introduction
11.11.4 Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.11.5 Novo Nordisk Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Pancreatic Beta-Cell Protection Introduction
11.12.4 Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.12.5 Sanofi Recent Development
11.13 Osiris Therapeutics
11.13.1 Osiris Therapeutics Company Detail
11.13.2 Osiris Therapeutics Business Overview
11.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Introduction
11.13.4 Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.13.5 Osiris Therapeutics Recent Development
11.14 Beta-O2 Technologies Ltd
11.14.1 Beta-O2 Technologies Ltd Company Detail
11.14.2 Beta-O2 Technologies Ltd Business Overview
11.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Introduction
11.14.4 Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.14.5 Beta-O2 Technologies Ltd Recent Development
11.15 Transition Therapeutics
11.15.1 Transition Therapeutics Company Detail
11.15.2 Transition Therapeutics Business Overview
11.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Introduction
11.15.4 Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2019-2024)
11.15.5 Transition Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Stem Cell Based
Table 3. Key Players of Gene Therapies
Table 4. Key Players of RNA Based Therapies
Table 5. Key Players of Monoclonal Antibodies (MAbs)
Table 6. Key Players of Phytotherapy
Table 7. Global Pancreatic Beta-Cell Protection Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Pancreatic Beta-Cell Protection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Pancreatic Beta-Cell Protection Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Pancreatic Beta-Cell Protection Market Share by Region (2019-2024)
Table 11. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Pancreatic Beta-Cell Protection Market Share by Region (2025-2030)
Table 13. Pancreatic Beta-Cell Protection Market Trends
Table 14. Pancreatic Beta-Cell Protection Market Drivers
Table 15. Pancreatic Beta-Cell Protection Market Challenges
Table 16. Pancreatic Beta-Cell Protection Market Restraints
Table 17. Global Pancreatic Beta-Cell Protection Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Pancreatic Beta-Cell Protection Market Share by Players (2019-2024)
Table 19. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Beta-Cell Protection as of 2023)
Table 20. Ranking of Global Top Pancreatic Beta-Cell Protection Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Pancreatic Beta-Cell Protection Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pancreatic Beta-Cell Protection Product Solution and Service
Table 24. Date of Enter into Pancreatic Beta-Cell Protection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pancreatic Beta-Cell Protection Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2019-2024)
Table 28. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2025-2030)
Table 30. Global Pancreatic Beta-Cell Protection Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2019-2024)
Table 32. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2025-2030)
Table 34. North America Pancreatic Beta-Cell Protection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Pancreatic Beta-Cell Protection Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Pancreatic Beta-Cell Protection Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Pancreatic Beta-Cell Protection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Pancreatic Beta-Cell Protection Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Pancreatic Beta-Cell Protection Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Pancreatic Beta-Cell Protection Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Pancreatic Beta-Cell Protection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Pancreatic Beta-Cell Protection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2025-2030) & (US$ Million)
Table 49. ViaCyte Company Detail
Table 50. ViaCyte Business Overview
Table 51. ViaCyte Pancreatic Beta-Cell Protection Product
Table 52. ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 53. ViaCyte Recent Development
Table 54. PharmaCyte Biotech Company Detail
Table 55. PharmaCyte Biotech Business Overview
Table 56. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product
Table 57. PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 58. PharmaCyte Biotech Recent Development
Table 59. Boehringer Ingelheim Company Detail
Table 60. Boehringer Ingelheim Business Overview
Table 61. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product
Table 62. Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 63. Boehringer Ingelheim Recent Development
Table 64. GalaxoSmithKline Company Detail
Table 65. GalaxoSmithKline Business Overview
Table 66. GalaxoSmithKline Pancreatic Beta-Cell Protection Product
Table 67. GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 68. GalaxoSmithKline Recent Development
Table 69. Beta-Cell NV Company Detail
Table 70. Beta-Cell NV Business Overview
Table 71. Beta-Cell NV Pancreatic Beta-Cell Protection Product
Table 72. Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 73. Beta-Cell NV Recent Development
Table 74. Novartis Company Detail
Table 75. Novartis Business Overview
Table 76. Novartis Pancreatic Beta-Cell Protection Product
Table 77. Novartis Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Janssen Research & Development Company Detail
Table 80. Janssen Research & Development Business Overview
Table 81. Janssen Research & Development Pancreatic Beta-Cell Protection Product
Table 82. Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 83. Janssen Research & Development Recent Development
Table 84. Pfizer Inc Company Detail
Table 85. Pfizer Inc Business Overview
Table 86. Pfizer Inc Pancreatic Beta-Cell Protection Product
Table 87. Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 88. Pfizer Inc Recent Development
Table 89. BioLineRx Company Detail
Table 90. BioLineRx Business Overview
Table 91. BioLineRx Pancreatic Beta-Cell Protection Product
Table 92. BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 93. BioLineRx Recent Development
Table 94. Genentech Company Detail
Table 95. Genentech Business Overview
Table 96. Genentech Pancreatic Beta-Cell Protection Product
Table 97. Genentech Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 98. Genentech Recent Development
Table 99. Novo Nordisk Company Detail
Table 100. Novo Nordisk Business Overview
Table 101. Novo Nordisk Pancreatic Beta-Cell Protection Product
Table 102. Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 103. Novo Nordisk Recent Development
Table 104. Sanofi Company Detail
Table 105. Sanofi Business Overview
Table 106. Sanofi Pancreatic Beta-Cell Protection Product
Table 107. Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 108. Sanofi Recent Development
Table 109. Osiris Therapeutics Company Detail
Table 110. Osiris Therapeutics Business Overview
Table 111. Osiris Therapeutics Pancreatic Beta-Cell Protection Product
Table 112. Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 113. Osiris Therapeutics Recent Development
Table 114. Beta-O2 Technologies Ltd Company Detail
Table 115. Beta-O2 Technologies Ltd Business Overview
Table 116. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product
Table 117. Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 118. Beta-O2 Technologies Ltd Recent Development
Table 119. Transition Therapeutics Company Detail
Table 120. Transition Therapeutics Business Overview
Table 121. Transition Therapeutics Pancreatic Beta-Cell Protection Product
Table 122. Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2019-2024) & (US$ Million)
Table 123. Transition Therapeutics Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Beta-Cell Protection Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pancreatic Beta-Cell Protection Market Share by Type: 2023 VS 2030
Figure 3. Stem Cell Based Features
Figure 4. Gene Therapies Features
Figure 5. RNA Based Therapies Features
Figure 6. Monoclonal Antibodies (MAbs) Features
Figure 7. Phytotherapy Features
Figure 8. Global Pancreatic Beta-Cell Protection Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Pancreatic Beta-Cell Protection Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Medical Research Laboratory Case Studies
Figure 12. Others Case Studies
Figure 13. Pancreatic Beta-Cell Protection Report Years Considered
Figure 14. Global Pancreatic Beta-Cell Protection Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Pancreatic Beta-Cell Protection Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Pancreatic Beta-Cell Protection Market Share by Region: 2023 VS 2030
Figure 17. Global Pancreatic Beta-Cell Protection Market Share by Players in 2023
Figure 18. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Beta-Cell Protection as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Pancreatic Beta-Cell Protection Revenue in 2023
Figure 20. North America Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Pancreatic Beta-Cell Protection Market Share by Country (2019-2030)
Figure 22. United States Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Pancreatic Beta-Cell Protection Market Share by Country (2019-2030)
Figure 26. Germany Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Region (2019-2030)
Figure 34. China Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Pancreatic Beta-Cell Protection Market Share by Country (2019-2030)
Figure 42. Mexico Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Country (2019-2030)
Figure 46. Turkey Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Pancreatic Beta-Cell Protection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. ViaCyte Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 49. PharmaCyte Biotech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 51. GalaxoSmithKline Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 52. Beta-Cell NV Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 53. Novartis Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 54. Janssen Research & Development Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 55. Pfizer Inc Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 56. BioLineRx Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 57. Genentech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 58. Novo Nordisk Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 59. Sanofi Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 60. Osiris Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 61. Beta-O2 Technologies Ltd Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 62. Transition Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock